Lv5
820 积分 2024-06-11 加入
EGFR Mutations and Lung Cancer
24天前
已完结
A tetraspecific engager armed with a non-alpha IL-2 variant harnesses natural killer cells against B cell non-Hodgkin lymphoma
1个月前
已完结
Inhibiting intracellular CD28 in cancer cells enhances antitumor immunity and overcomes anti-PD-1 resistance via targeting PD-L1
1个月前
已完结
A tetraspecific engager armed with a non-alpha IL-2 variant harnesses natural killer cells against B cell non-Hodgkin lymphoma
1个月前
已完结
Target antigen and plasma cell phenotype are critical factors for sensitivity to response-adapted daratumumab therapy
2个月前
已完结
Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition
4个月前
已完结
A tetraspecific engager armed with a non-alpha IL-2 variant harnesses natural killer cells against B cell non-Hodgkin lymphoma
4个月前
已完结
Nanobody-Engineered Bispecific IL-18 Mimetics Drive Antitumor Immunity by Engaging CD8+ T Cells and Evading IL-18BP in Preclinical Models
4个月前
已完结
Natural Killer Cell Signaling Pathways
6个月前
已完结
Stress Factors in mAb Drug Substance Production Processes: Critical Assessment of Impact on Product Quality and Control Strategy
7个月前
已完结
皖公网安备34019202002308
